Lagevrio

Lagevrio Coupons & Discount Card - Compare Prices Near You

Molnupiravir, also known as Lagevrio, is an antiviral medication authorized for emergency use by the FDA to treat adults with mild to moderate COVID-19 symptoms. It is intended for individuals who have experienced symptoms for no more than five days, are not hospitalized, and are at high risk of developing severe illness due to factors like older age, obesity, or certain medical conditions such as lung or heart disease, or diabetes. Molnupiravir functions by disrupting the replication process of the virus, thereby preventing it from multiplying and spreading further in the body. Prescribed as an oral capsule, the treatment spans five days. While generally well-tolerated, some individuals may experience side effects like diarrhea, nausea, and dizziness. There are no known interactions with other medications. It is crucial for patients to discuss the potential risks and benefits of molnupiravir with their healthcare provider. Although emerging data suggest it may help reduce hospitalizations, its safety and efficacy remain under continuous evaluation. This medication is not for use in hospitalized patients. Always consult with a healthcare professional for personalized medical advice.
Our Lagevrio coupons are free to use. You can print the coupon, email it to yourself, or receive the Lagevrio coupon via text message. To get your free discount, show the pharmacist your Lagevrio savings card which has the discounted coupon price. Use our filters below to edit the prescription box to match your needs. The Lagevrio prices will update based on your prescription needs. Above our Lagevrio coupons, you can change the location to see pharmacy prices in other areas. Our prescription discount card will update online with the specific pharmacy costs associated with your edits. Be sure to text, email, or print the Lagevrio savings card code that you need after editing the prescription box and location field. Show the discount card to your pharmacist before paying.

My prescription

Edit

200MG, Lagevrio (30 Capsules)

Select pharmacy

Pharmacy logo

CVS

$719.10

COUPON PRICE
Pharmacy logo

Walmart

$1.01

COUPON PRICE
Pharmacy logo

Rite Aid

$735.92

COUPON PRICE
Pharmacy logo

Walgreens

$768.32

COUPON PRICE

Lagevrio savings card

Show this card to your pharmacist
Pharmacy logo

CVS

$719.10

BIN

ID

PCN

GRP

019876

LH727CF7E0

CHIPPO

LHX

Powered by

This card is not insurance

Related nucleoside analogue antivirals prescriptions

coupons from$6784.78 
coupons from$157329.5 
coupons from$1.01 

More prescriptions for COVID-19

coupons from$152.7Save 72%
coupons from$152.7Save 72%
coupons from$1435Save 73%
coupons from$1.75 
coupons from$1.76Save 86%
coupons from$152.7Save 72%
coupons from$152.7Save 72%
coupons from$1.01 

Related nucleoside analogue antivirals prescriptions

Livtencitycoupons from $6784.78
Virazolecoupons from $157329.5
Tembexacoupons from $1.01

More prescriptions for COVID-19

Flowflex Covid-19 Ag Home Test Save 72%coupons from $152.7
Fastep Covid-19 Antigen Test Save 72%coupons from $152.7
Paxlovid (300/100) Save 73%coupons from $1435
Imdevimabcoupons from $1.75
Casirivimab Save 86%coupons from $1.76
Binaxnow Covid-19 Ag Home Test Save 72%coupons from $152.7
Genabio Covid-19 Rapid Test Save 72%coupons from $152.7
Evusheldcoupons from $1.01

Lagevrio dosage forms

The average cost for 30 Capsules of Lagevrio at 200MG is $1.01 with a free coupon. This is 0.05% off the average retail price of $1973.17
DosageQuantityPrice fromPer unit
200MG30 Capsules$1.01$0.03

Lagevrio Warnings

This medication comes with several important safety warnings, which you should carefully review. If you have any concerns or questions, please consult your healthcare provider.

  • Risk of Birth Defects: There is a potential risk for birth defects in infants born to mothers who use Lagevrio (molnupiravir) during pregnancy. To mitigate this risk, a pregnancy test may be recommended before initiating treatment. In some cases, the benefits of using Lagevrio during pregnancy may outweigh the risks. If you choose to proceed with this treatment while pregnant, participation in the COVID-19 International Pregnancy Registry is highly encouraged.

  • Bone and Cartilage Damage: This medication is not suitable for individuals under 18 years of age due to the risk of bone and cartilage damage. If you experience symptoms such as joint or bone pain, swelling, or a clicking or grinding sensation in the joints, inform your healthcare provider immediately.

  • Serious Allergic Reactions: Although rare, some individuals may experience serious allergic reactions to Lagevrio (molnupiravir). Seek immediate medical attention if you notice any symptoms of anaphylaxis, such as facial swelling, difficulty breathing, or hives.

There are no known contraindications for this medication at present. Always discuss any concerns or medical conditions with your healthcare provider before starting any new medication.

Lagevrio Side Effects

When taking this medication, you may experience some mild side effects, including diarrhea, nausea, and dizziness. These symptoms are generally not serious and may subside as your body adjusts to the medication. However, if these effects persist or worsen, it's important to inform your healthcare provider to ensure proper management.

On rare occasions, some individuals may experience serious allergic reactions to this drug. Symptoms of such a reaction can include a rash, itching, swelling (particularly of the face, tongue, or throat), severe dizziness, and trouble breathing. These symptoms require immediate medical attention to prevent complications.

It's crucial to note that while these side effects have been reported, the full range of possible side effects is not completely known at this time. Always communicate any unusual symptoms to your healthcare provider to ensure your safety while using this medication.

Lagevrio Interactions

Currently, there is no known information regarding drug interactions with molnupiravir.
Lagevrio FAQs
What is the drug Lagevrio used for?

Lagevrio is used for the treatment of mild to moderate COVID-19 in adults who are at high risk for progressing to severe disease, including hospitalization or death.

The effectiveness of Lagevrio (molnupiravir) versus Paxlovid (nirmatrelvir/ritonavir) can vary depending on individual patient circumstances, including the severity of the COVID-19 infection, underlying health conditions, and potential drug interactions. Paxlovid has generally shown higher efficacy in reducing the risk of hospitalization and death in clinical trials compared to Lagevrio. However, the choice between these medications should be made by a healthcare provider, who can consider the specific needs and medical history of the patient.

Lagevrio, also known as molnupiravir, may have several potential downsides or side effects. Common side effects include diarrhea, nausea, and dizziness. There is also a concern about its potential to cause mutations, which could theoretically lead to long-term effects, although this risk is still being studied. Additionally, it is not recommended for use during pregnancy due to potential risks to the fetus. As with any medication, it is important to discuss potential risks and benefits with a healthcare provider.

Lagevrio (molnupiravir) has been shown to be effective in reducing the risk of hospitalization and death in patients with mild to moderate COVID-19 who are at high risk for severe disease. Clinical trials have demonstrated that it can decrease the likelihood of progression to severe illness when administered early in the course of the infection. However, its effectiveness may vary based on individual patient factors and the specific variant of the virus. It is important for patients to consult with their healthcare provider to determine if Lagevrio is an appropriate treatment option for their situation.

The effectiveness of COVID-19 antiviral treatments can vary based on several factors, including the specific variant of the virus, the timing of administration, and the individual patient's health condition. As of the latest data, Paxlovid (nirmatrelvir/ritonavir) and remdesivir are among the most commonly used antivirals for treating COVID-19. Paxlovid is often preferred for its oral administration and effectiveness in reducing the risk of severe illness when taken early in the course of the disease. Remdesivir is typically administered intravenously and is used in hospitalized patients. It is important for healthcare providers to consider the specific circumstances of each patient when determining the most appropriate treatment.